Incannex Healthcare using medicinal cannabis to treat illnesses with unmet needs

Incannex Healthcare (ASX: IHL) chief medical officer Dr Sud Agarwal joins Small Caps to discuss the company’s clinical trials involving medicinal cannabis to treat a number of ailments including: obstructive sleep apnoea (OSA), sepsis associated acute respiratory distress syndrome (SAARDS) and traumatic brain injury (TBI).

For more information:
https://smallcaps.com.au/stocks/?symbol=IHL

———————–

Small Caps is Australia’s #1 site for market news & information on ASX listed small cap companies.

———————–

WEBSITE
https://smallcaps.com.au/

PODCAST
https://smallcaps.com.au/podcast/

SOCIAL MEDIA
Facebook: https://www.facebook.com/SmallCapsASX
Twitter: https://twitter.com/SmallCapsASX
LinkedIn: https://www.linkedin.com/company/small-caps/

NEWSLETTER
https://smallcaps.com.au/subscribe/

source